Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AMED

Amedisys (AMED) Stock Price, News & Analysis

Amedisys logo

About Amedisys Stock (NASDAQ:AMED)

Key Stats

Today's Range
$100.93
$101.02
50-Day Range
$96.91
$101.01
52-Week Range
$82.15
$101.02
Volume
1.06 million shs
Average Volume
780,222 shs
Market Capitalization
$3.32 billion
P/E Ratio
39.30
Dividend Yield
N/A
Price Target
$100.50
Consensus Rating
Moderate Buy

Company Overview

Amedisys Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

AMED MarketRank™: 

Amedisys scored higher than 33% of companies evaluated by MarketBeat, and ranked 764th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Amedisys has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Upside/Downside

    The consensus price target for Amedisys is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Amedisys has received no research coverage in the past 90 days.

  • Read more about Amedisys' stock forecast and price target.
  • Earnings Growth

    Earnings for Amedisys are expected to grow by 10.00% in the coming year, from $4.40 to $4.84 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Amedisys is 39.30, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 267.74.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Amedisys is 39.30, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 86.88.

  • Price to Earnings Growth Ratio

    Amedisys has a PEG Ratio of 1.34. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Amedisys has a P/B Ratio of 2.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Amedisys' valuation and earnings.
  • Short Interest

    There is no current short interest data available for AMED.
  • Dividend Yield

    Amedisys does not currently pay a dividend.

  • Dividend Growth

    Amedisys does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for AMED.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Amedisys this week, compared to 5 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Amedisys insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.10% of the stock of Amedisys is held by insiders.

  • Percentage Held by Institutions

    94.36% of the stock of Amedisys is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Amedisys' insider trading history.
Receive AMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amedisys and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AMED Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.tc pixel
Why UnitedHealth (UNH) Stock Is Trading Up Today
UnitedHealth Leaps on Medicare Star Ratings
UnitedHealth Surges on Medicare Bonus Outlook
See More Headlines

AMED Stock Analysis - Frequently Asked Questions

Amedisys, Inc. (NASDAQ:AMED) posted its earnings results on Tuesday, July, 29th. The health services provider reported $1.54 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.15. The company's quarterly revenue was up 5.2% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Amedisys investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AU Optronics (AUOTY).

Company Calendar

Last Earnings
7/29/2025
Today
10/04/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:AMED
CIK
896262
Employees
20,000
Year Founded
1982

Price Target and Rating

High Price Target
$101.00
Low Price Target
$100.00
Potential Upside/Downside
-0.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.57
Trailing P/E Ratio
39.30
Forward P/E Ratio
22.96
P/E Growth
1.34
Net Income
$43.23 million
Net Margins
3.56%
Pretax Margin
6.21%
Return on Equity
12.91%
Return on Assets
7.29%

Debt

Debt-to-Equity Ratio
0.26
Current Ratio
1.36
Quick Ratio
1.36

Sales & Book Value

Annual Sales
$2.40 billion
Price / Sales
1.38
Cash Flow
$6.24 per share
Price / Cash Flow
16.20
Book Value
$38.77 per share
Price / Book
2.61

Miscellaneous

Outstanding Shares
32,887,000
Free Float
32,196,000
Market Cap
$3.32 billion
Optionable
Optionable
Beta
0.89

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:AMED) was last updated on 10/5/2025 by MarketBeat.com Staff
From Our Partners